These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11739150)

  • 1. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
    Storek J; Joseph A; Espino G; Dawson MA; Douek DC; Sullivan KM; Flowers ME; Martin P; Mathioudakis G; Nash RA; Storb R; Appelbaum FR; Maloney DG
    Blood; 2001 Dec; 98(13):3505-12. PubMed ID: 11739150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
    Storek J; Dawson MA; Storer B; Stevens-Ayers T; Maloney DG; Marr KA; Witherspoon RP; Bensinger W; Flowers ME; Martin P; Storb R; Appelbaum FR; Boeckh M
    Blood; 2001 Jun; 97(11):3380-9. PubMed ID: 11369627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients.
    Hammarström V; Pauksen K; Svensson H; Lönnqvist B; Simonsson B; Ringdén O; Ljungman P
    Transplantation; 2000 Apr; 69(8):1582-6. PubMed ID: 10836366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts.
    Storek J; Gooley T; Witherspoon RP; Sullivan KM; Storb R
    Am J Hematol; 1997 Feb; 54(2):131-8. PubMed ID: 9034287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.
    Hammarström V; Pauksen K; Azinge J; Oberg G; Ljungman P
    Support Care Cancer; 1993 Jul; 1(4):195-9. PubMed ID: 8193881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
    Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reconstitution assessed during five years after allogeneic bone marrow transplantation.
    Fujimaki K; Maruta A; Yoshida M; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Bone Marrow Transplant; 2001 Jun; 27(12):1275-81. PubMed ID: 11548845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.
    van Leeuwen JE; van Tol MJ; Joosten AM; Schellekens PT; van den Bergh RL; Waaijer JL; Oudeman-Gruber NJ; van der Weijden-Ragas CP; Roos MT; Gerritsen EJ
    Blood; 1994 Dec; 84(11):3936-47. PubMed ID: 7949150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of pre-transplant circulating CD3
    Kim TW; Lee SE; Lim JY; Ryu DB; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Min CK
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27910184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Otheo E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1996 Feb; 106(5):169-73. PubMed ID: 8684015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants.
    Rocha V; Carmagnat MV; Chevret S; Flinois O; Bittencourt H; Esperou H; Garnier F; Ribaud P; Devergie A; Socié G; Dal'Cortivo L; Marolleau JP; Charron D; Gluckman E; Rabian C
    Exp Hematol; 2001 Nov; 29(11):1347-52. PubMed ID: 11698131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.
    Keever CA; Small TN; Flomenberg N; Heller G; Pekle K; Black P; Pecora A; Gillio A; Kernan NA; O'Reilly RJ
    Blood; 1989 Apr; 73(5):1340-50. PubMed ID: 2649174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation.
    Storek J; Espino G; Dawson MA; Storer B; Flowers ME; Maloney DG
    Blood; 2000 Nov; 96(9):3290-3. PubMed ID: 11050018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of lymphocyte subsets in leukemia patients who received allogenic bone marrow transplantation.
    Komatsuda M
    Acta Med Okayama; 1991 Aug; 45(4):257-65. PubMed ID: 1683740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation.
    Perlingeiro Beltrame M; Malvezzi M; Bonfim C; Covas DT; Orfao A; Pasquini R
    Cytotherapy; 2014 Jul; 16(7):976-89. PubMed ID: 24831839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.